Oxidative stress in mild cognitive impairment and Alzheimer disease: A continuum

Journal of Alzheimer's Disease

Volumn 6, Issue 2, 2004, Pages 159-163

  Mecocci, Patrizia ^a  

^a POLICLINICO MONTELUCE   (Italy)

Author keywords

Alzheimer's disease; Antioxidants; Mild cognitive impairment; Oxidative stress

Indexed keywords

ALPHA CAROTENE; ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BLEOMYCIN; CAROTENOID; FREE RADICAL; GINKGO BILOBA EXTRACT; GLUTATHIONE PEROXIDASE; RETINOL; SUPEROXIDE DISMUTASE; URIC ACID DERIVATIVE; XANTHOPHYLL; ZEAXANTHIN;

ALZHEIMER DISEASE; ANTIOXIDANT ACTIVITY; CLINICAL TRIAL; COGNITIVE DEFECT; CORRELATION ANALYSIS; DIET THERAPY; HUMAN; NEUROPATHOLOGY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; RISK FACTOR; VITAMIN BLOOD LEVEL;

EID: 2342429093     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2004-6207     Document Type: Review

References (41)

1. A. Azzi, R. Stocker and E. Vitamin, non-antioxidant roles, Prog Lipid Res 39 (2000), 231-255.
2. T. Berger, M.C. Polidori, A. Dabbagh, P. Evans, B. Halliwell, J. Morrow, L.J. Roberta II and B. Frei, Antioxidant activity of vitamin C in iron-overloaded human plasma, J Biol Chem 272 (1997), 15656-15660.
3. D.A. Bota, H. van Remmen and K.J.A. Davies, Modulation of Lon protease activity and aconitase turnover during aging and oxidative stress, FEBS Letters 532 (2002), 103-106.
4. J.L. Bradley, J.C. Blake, S. Chamberlain, P.K. Thomas, J.M. Cooper and A.H. Schapira, Clinical, biochemical and molecular genetic correlations in Friedreich's ataxia, Hum Mol Genet 22 (2000), 275-282.
5. P. Di Mascio, S. Kaiser and H. Sies, Lycopene as the most efficient biological carotenoid singlet oxygen quencher, Arch Biochem Biophys 274 (1989), 532-538.
6. R. Duara, C.L. Grady and J.V Haxby, et al., Positron emission tomography in Alzheimer's disease, Neurology 36 (1986), 879-887.
7. M.J. Engelhart, M.I. Geerlings, A. Ruitenberg, J.C. van Swieten, A. Hofman, J.C. Witteman and M.M. Breteler, Dietary intake of antioxidants and risk of Alzheimer disease, JAMA 287 (2002), 3223-3229.
8. R.A. Floyd and K. Hensley, Oxidative stress in brain aging. Implications for therapeutics of neurodegenerative diseases, Neurobiol Aging 23 (2002), 795-807.
9. B. Frei, L. England and B.N. Ames, Ascorbate is an outstanding antioxidant in human plasma, Proc Natl Acad Sci USA 86 (1989), 6377-6381.
10. F.J. Jiménez-Jiménez, F. de Bustos and J.A. Molina, et al., Cerebrospinal fluid levels of alpha-tocopherol (vitamin E) in Alzheimer's disease, J Neural Transm 104 (1997), 703-710.
11. F.J. Jiménez-Jiménez, J.A. Molina and F. de Bustos, et al., Serum levels of β-carotene, α-carotene and vitamin A in patients with Alzheimer's disease, Eur J Neurol 6 (1999), 495-497.
12. M.B. Kadiiska, B.C. Gladen, D.D. Baird, A.E. Dikalova, R.S. Sohal, G.E. Hatch, D.P. Jones, R.P. Mason and J.C. Barrett, Biomarkers of oxidative stress study: are plasma antioxidants markers of CCl(4)poisoning? Free Radic Biol Med 28 (2000), 838-485.
13. P.L. Le Bars, F.M. Velasco, J.M. Ferguson, E.C. Dessain, M. Kieser and R. Hoerr, Influence of the severity of cognitive impairment on the effect of the Ginkgo biloba extract EGb 761 in Alzheimer's disease, Neuropsychobiology 45 (2002), 19-26.
14. W.R. Markesbery and J.M. Carney, Oxidative alterations in Alzheimer's disease, Brain Pathol 9 (1999), 133-146.
15. P. Mecocci, U. MacGarvey and M.E Beal, Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease, Ann Neurol 36 (1994), 747-751.
16. P. Mecocci, M.C. Polidori, T. Ingegni, A. Cherubini, F. Chionne, R. Cecchetti and U. Senin, Oxidative damage to DNA in lymphocytes from AD patients, Neurology 51 (1998), 1014-1017.
17. P. Mecocci, M.C. Polidori, T. Ingegni, A. Cherubini, P. Mattioli, M. Catani, P. Rinaldi, R. Cecchetti, W. Stahl, U. Senin and M.F. Beal, Lymphocyte oxidative DNA damage and plasma antioxidants in Alzheimer disease, Arch Neurol 59 (2002), 794-798.
18. T.J. Montine, J.F. Quinn, D. Milatovic, L.C. Silbert, T. Dang, S. Sanchez, E. Terry, L.J. Roberts 2nd, J.A. Kaye and J.D. Morrow, Peripheral F2-isoprostanes and F4-neuroprostanes are not increased in Alzheimer's disease, Ann Neurol 52 (2002), 175-179.
19. M.C. Morris, D.A. Evans, J.L. Bienias, C.C. Tangney and R.S. Wilson, Vitamin E and cognitive decline in older persons, Arch Neurol 59 (2002), 1125-1132.
20. A. Nunomura, G. Perry, M.A. Pappolla, R.P. Friedland, K. Hirai, S. Chiba and M.A. Smith, Neuronal oxidative stress precedes amyloid-beta deposition in Down syndrome, J Neuropathol Exp Neurol 59 (2000), 1011-1017.
21. J. Ojaimi and E. Byrne, Mtochondrial function and Alzheimer's disease, Biol Signals Recept 10 (2001), 254-262.
22. R.M. Ortega, A.M. Requejo, A.M. Lopez-Sobaler, P. Andres, B. Navia, J.M. Perea and F. Robles, Cognitive function in elderly people is affected by vitamin E status, J Nutr 132 (2002), 2065-2068.
23. L.C. Park, D.S. Albers, H. Xu, J.G. Lindsay, M.F. Beal and G.E. Gibson, Mitochondrial impairment in the cerebellum of the patients with progressive supranuclear palsy, J Neurosci Res 66 (2001), 1028-1034.
24. W.J. Perrig, P. Perrig and H.B. Stähelin, The relation between antioxidants and memory performance in the old and very old, J Am Geriatr Soc 45 (1997), 718-724.
25. R.C. Petersen, G.E. Smith, S.C. Waring, R.J. Ivnik, E.G. Tangalos and E. Kokmen, Mild cognitive impairment: clinical characterization and outcome, Arch Neurol 56 (1999), 303-308.
26. M.C. Polidori and P. Mecocci, Plasma susceptibility to free radical-induced antioxidant consumption and lipid peroxidation is increased in very old subjects with Alzheimer disease, J Alzheimers Dis 4 (2002), 513-518.
27. M.C. Polidori, W. Stahl, O. Eichler, I. Niestroj and H. Sies, Profiles of antioxidants in human plasma, Free Radic Biol Med 30 (2001), 456-462.
28. 2α -VI in Alzheimer's disease: correlation of a noninvasive index of lipid peroxidation with disease severity, Ann Neurol 48 (2000), 809-812.
29. D. Praticò, C.M. Clark, F. Liun, V.Y. Lee and J.Q. Trojanowski, Increase of brain oxidative stress in mild cognitive impairment: a possible predictor of Alzheimer disease, Arch Neurol 59 (2002), 972-976.
30. D. Praticó, U. Uryu, S. Leight, J.Q. Trojanowski and VM-Y. Lee, Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis, J Neurosci 21 (2001), 4183-4187.
31. C. Richter, J.W. Park and B.N. Ames, Normal oxidative damage to mitochondrial and nuclear DNA is extensive, Proc Natl Acad Sci USA 85 (1988), 6465-6467.
32. S. Riviére, I. Birlouez-Aragon, F. Nourashémi and B. Vellas, Low plasma vitamin C in Alzheimer patients despite an adequate diet, Int J Geriatr Psych 13 (1998), 749-754.
33. M. Sano, C. Emesto, R.G. Thomas, M.R. Klauber, K. Schafer, M. Grundman, P. Woodbury, J. Growdon, C.W. Cotman, E. Pfeiffer, L.S. Schneider and L.J. Thal, A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study, N Engl J Med 336 (1997), 1216-1222.
34. H. Sies, W. Stahl and M.C. Polidori, Oxidative Stress: antioxidants in degenerative neurological and ophthalmological disorders, in: Genetic Expression and Nutrition, C. Bachmann and B. Koletzko, eds, Nestlé Nutrition Workshop Series, Vol. 50. Nestec Ltd., Vevey/Lippincott Williams & Wilkins, Philadelphia, 2003, pp. 107-118.
35. A.J. Sinclair, A.J. Bayer, J. Johnston, C. Warner, S.R.J. Maxwell, Altered plasma antioxidant status in subjects with Alzheimer's disease and vascular dementia, Int J Geriatr Psych 13 (1998), 840-845.
36. M.A. Smith, A. Nunomura, X. Zhu, A. Takeda and G. Perry, Metabolic, metallic, and mitotic sources of oxidative stress in Alzheimer disease, Antioxid Redox Signal 2 (2000), 413-420.
37. S. Sung, Y. Yao, K. Uryu, H. Yang, V.M. Lee, J.Q. Trojanowski and D. Praticò, Early Vitamin E supplementation in young but not aged mice reduces Abeta levels and amyloid deposition in a transgenic model of Alzheimer's disease, FASEB J (2003) (in press).
38. SJ. Tabrizi and A.H. Schapira, Secondary abnormalities of mitochondrial DNA associated with neurodegeneration, Biochem Soc Symp 66 (1999), 99-110.
39. K. Uryu, H. Laurer, T. McIntosh, D. Praticó, D. Martinez, S. Leight, VM-Y. Lee and J.Q. Trojanowsld, Repetitive mild brain trauma accelerates Aβ deposition, lipid peroxidation, and cognitive impairment in a transgenic mouse model of Alzheimer amyloidosis, J Neurosci 22:4 (2002), 46-454.
40. S. Vásquez-Vivar, B. Kalyanaraman and M.C. Kennedy, Mitochondrial aconitase is a source of hydroxyl radical, J Biol Chem 275 (2000), 14064-14069.
41. L.-J. Yan, R.L. Levine and R.S. Sohal, Oxidative damage during aging targets mitochondrial aconitase, Proc Natl Acad Sci USA 94 (1997), 11168-11172.